Skip to main content
Erschienen in: Head and Neck Pathology 1/2020

01.04.2019 | Case Report

Salivary Duct Carcinoma of the Parotid Gland Originating from an Epithelial-Myoepithelial Carcinoma: Report of a Rare Case

verfasst von: Yuichiro Hamamoto, Hiroshi Harada, Motoyuki Suzuki, Takashi Fujii, Shin-ichi Nakatsuka

Erschienen in: Head and Neck Pathology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Salivary duct carcinoma (SDC) is a high-grade carcinoma with poor prognosis, especially among various salivary carcinomas. In this study, we report a rare case of SDC of the parotid gland originating from an epithelial-myoepithelial carcinoma (EMC). A 71-year-old Japanese man presented with swelling of the right parotid region and a right facial nerve paralysis for 10 months. He underwent extended total parotidectomy and chemoradiotherapy after the surgery. Histologically, a major part of the tumor was an androgen receptor (AR)-positive, human epidermal growth factor receptor 2 (HER2)-positive, gross cystic disease fluid protein-15 (GCDFP-15)-positive SDC, with a focus of a typical EMC component at the periphery of the lesion. In the transitional area of the two components, inner ductal cells of double-layered ducts showed similar morphology and immunophenotype to SDC. These findings suggest that SDC originated from the inner ductal cells of EMC. Because the tumor included an EMC as a low-grade carcinoma and an SDC as a high-grade carcinoma, we can consider our case as a dedifferentiated carcinoma as well as a hybrid tumor.
Literatur
1.
Zurück zum Zitat Adel K, et al. WHO classification of head and neck tumours. Lyon: IARC Press; 2017. pp. 173–5. Adel K, et al. WHO classification of head and neck tumours. Lyon: IARC Press; 2017. pp. 173–5.
2.
Zurück zum Zitat Seifert G, et al. Hybrid tumors of salivary glands. Definition and classification of five rare cases. Eur J Cancer B. 1996;32:251–9.CrossRef Seifert G, et al. Hybrid tumors of salivary glands. Definition and classification of five rare cases. Eur J Cancer B. 1996;32:251–9.CrossRef
3.
Zurück zum Zitat Croitoru CM, et al. Hybrid carcinomas of the salivary glands. Report of 4 cases and review of the literature. Arch Pathol Lab Med. 1999;123:698–702.PubMed Croitoru CM, et al. Hybrid carcinomas of the salivary glands. Report of 4 cases and review of the literature. Arch Pathol Lab Med. 1999;123:698–702.PubMed
4.
Zurück zum Zitat Zardawi IM. Hybrid carcinoma of the salivary gland. Histopathology. 2000;37:283–4.CrossRef Zardawi IM. Hybrid carcinoma of the salivary gland. Histopathology. 2000;37:283–4.CrossRef
5.
Zurück zum Zitat Nagao T, et al. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic immunohistochemical, and p53 gene alteration analysis. Mod Pathol. 2002;15:724–33.CrossRef Nagao T, et al. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic immunohistochemical, and p53 gene alteration analysis. Mod Pathol. 2002;15:724–33.CrossRef
6.
Zurück zum Zitat Kainuma K, et al. Hybrid carcinoma of the parotid gland: report of a case (epithelial-myoepithelial carcinoma and salivary duct carcinoma) and review of the literature. Acta Otolaryngol. 2010;130:185–9.CrossRef Kainuma K, et al. Hybrid carcinoma of the parotid gland: report of a case (epithelial-myoepithelial carcinoma and salivary duct carcinoma) and review of the literature. Acta Otolaryngol. 2010;130:185–9.CrossRef
7.
Zurück zum Zitat Chênevert J, et al. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol. 2012;25:919–29.CrossRef Chênevert J, et al. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol. 2012;25:919–29.CrossRef
8.
Zurück zum Zitat Seethala RR, et al. New variants of epithelial-myoepithelial carcinoma: oncocytic-seba-ceous and apocrine. Arch Pathol Lab Med. 2009;133:950–9.PubMed Seethala RR, et al. New variants of epithelial-myoepithelial carcinoma: oncocytic-seba-ceous and apocrine. Arch Pathol Lab Med. 2009;133:950–9.PubMed
9.
Zurück zum Zitat Seethala RR. Oncocytic and apocrine epithelial myoepithelial carcinoma: novel variants of a challenging tumor. Head Neck Pathol. 2013;7:77–84.CrossRef Seethala RR. Oncocytic and apocrine epithelial myoepithelial carcinoma: novel variants of a challenging tumor. Head Neck Pathol. 2013;7:77–84.CrossRef
10.
Zurück zum Zitat Gnepp DR, et al. Salivary and lacrimal glands. In: Gnepp DR, editor. Diagnostic Surgical Pathology of the Head and Neck. Philadelphia: WB Saunders Co.; 2000. pp. 325–430. Gnepp DR, et al. Salivary and lacrimal glands. In: Gnepp DR, editor. Diagnostic Surgical Pathology of the Head and Neck. Philadelphia: WB Saunders Co.; 2000. pp. 325–430.
11.
Zurück zum Zitat Ballestin C, et al. Combined acinic cell mucoepidermoid carcinoma of the parotid gland. Report of a case with immunohistochemical study. APMIS. 1996;104:99–102.CrossRef Ballestin C, et al. Combined acinic cell mucoepidermoid carcinoma of the parotid gland. Report of a case with immunohistochemical study. APMIS. 1996;104:99–102.CrossRef
12.
Zurück zum Zitat Chetty R, et al. Hybrid carcinomas of the salivary glands. Arch Pathol Lab Med. 2000;124:494–6.PubMed Chetty R, et al. Hybrid carcinomas of the salivary glands. Arch Pathol Lab Med. 2000;124:494–6.PubMed
13.
Zurück zum Zitat Piana S, et al. Epstein-Barr-positive lymphoepithelial carcinoma and epi-myoepithelial cell carcinoma of the parotid gland: a hitherto unreported example of hybrid tumor. Virchows Arch. 2004;445:425–8.CrossRef Piana S, et al. Epstein-Barr-positive lymphoepithelial carcinoma and epi-myoepithelial cell carcinoma of the parotid gland: a hitherto unreported example of hybrid tumor. Virchows Arch. 2004;445:425–8.CrossRef
14.
Zurück zum Zitat Murphy JG, et al. Salivary hybrid tumor: adenoid cystic carcinoma and basal cell adenocarcinoma. Virchows Arch. 2006;448:236–8.CrossRef Murphy JG, et al. Salivary hybrid tumor: adenoid cystic carcinoma and basal cell adenocarcinoma. Virchows Arch. 2006;448:236–8.CrossRef
15.
Zurück zum Zitat Atay G, et al. Hybrid carcinoma of the parotid gland: ductal carcinoma and myoepithelial carcinoma. Kulak Burun Bogaz Ihtis Derg. 2014;24:46–9.CrossRef Atay G, et al. Hybrid carcinoma of the parotid gland: ductal carcinoma and myoepithelial carcinoma. Kulak Burun Bogaz Ihtis Derg. 2014;24:46–9.CrossRef
16.
Zurück zum Zitat Sabri A, et al. Hybrid tumor of the parotid gland: a case report and review of the literature. Case Rep Otolaryngol. 2015;2015:192453.PubMedPubMedCentral Sabri A, et al. Hybrid tumor of the parotid gland: a case report and review of the literature. Case Rep Otolaryngol. 2015;2015:192453.PubMedPubMedCentral
17.
Zurück zum Zitat Katoh M, et al. An orderly retreat: dedifferentiation is a regulated process. Proc Natl Acad Sci USA. 2004;101:7005–10.CrossRef Katoh M, et al. An orderly retreat: dedifferentiation is a regulated process. Proc Natl Acad Sci USA. 2004;101:7005–10.CrossRef
18.
Zurück zum Zitat Gnepp DR, et al. Salivary and lacrimal glands. In: Gnepp DR, editor. Diagnostic Surgical Pathology of the Head and Neck. 2nd ed. Philadelphia: Saunders; 2009. pp. 413–562.CrossRef Gnepp DR, et al. Salivary and lacrimal glands. In: Gnepp DR, editor. Diagnostic Surgical Pathology of the Head and Neck. 2nd ed. Philadelphia: Saunders; 2009. pp. 413–562.CrossRef
Metadaten
Titel
Salivary Duct Carcinoma of the Parotid Gland Originating from an Epithelial-Myoepithelial Carcinoma: Report of a Rare Case
verfasst von
Yuichiro Hamamoto
Hiroshi Harada
Motoyuki Suzuki
Takashi Fujii
Shin-ichi Nakatsuka
Publikationsdatum
01.04.2019
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2020
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-019-01034-0

Weitere Artikel der Ausgabe 1/2020

Head and Neck Pathology 1/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …